Article
Circulating tumor cell heterogeneity in neuroendocrine prostate cancer by single cell copy number analysis
12 Aug 2021
Abstract excerpt
Neuroendocrine prostate cancer is an aggressive variant of prostate cancer that may arise de novo or develop from pre-existing prostate adenocarcinoma as a mechanism of treatment resistance. The combined loss of tumor suppressors RB1, TP53, and PTEN are frequent in NEPC but also present in a subset of prostate adenocarcinomas. Most clinical and preclinical studies support a trans-differentiation process, whereby...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
